Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Neutral Zydus LifeSciences; target of Rs 1080: Motilal Oswal
Motilal Oswal recommended Neutral rating on Zydus LifeSciences with a target price of Rs 1080 in its research report dated May 20, 2026.
Taking Stock: Nifty below 24,200, Sensex slips 516 pts amid global tensions; IT stocks shine
Among sectors, except IT, Healthcare, Consumer Durables and FMCG, all other indices ended in the red with PSU Bank index slipped 3%, Oil & Gas index shed 1%, while Private Bank, Metal, Energy, Power, Realty down 0.5% each.
Neutral Blue Star; target of Rs 1920: Motilal Oswal
Motilal Oswal recommended Neutral rating on Blue Star with a target price of Rs 1920 in its research report dated May 07, 2026.
Buy Ajanta Pharma; target of Rs 3400: Motilal Oswal
Motilal Oswal is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 3400 in its research report dated May 05, 2026.
Buy Laurus Labs; target of Rs 1370: Motilal Oswal
Motilal Oswal is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 1370 in its research report dated April 30, 2026.
Neutral Indegene; target of Rs 552: Motilal Oswal
Motilal Oswal recommended Neutral rating on Indegene with a target price of Rs 552 in its research report dated May 02, 2026.
Taking Stock: Market recovers but Nifty ends below 24,000; Sensex falls 583 pts
More than 100 stocks touched their 52-week high on the BSE, including Himadri Speciality, HFCL, Sai Life Sciences, Coal India, Hitachi Energy, Navin Fluorine, ONGC, Apar Industries, MCX India, Lloyds Metals, Chennai Petro, among others.
Buy Five Star Business Finance; target of Rs 600: Motilal Oswal
Motilal Oswal is bullish on Five Star Business Finance has recommended buy rating on the stock with a target price of Rs 600 in its research report dated April 29, 2026.
Buy Granules India; target of Rs 820: Motilal Oswal
Motilal Oswal is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 820 in its research report dated April 29, 2026.
Buy Niva Bupa Health Insurance; target of Rs 100: Motilal Oswal
Motilal Oswal recommended is bullish on Niva Bupa Health Insurance recommended buy rating on the stock with a target price of Rs 100 in its research report dated Jun 19, 2026.
Buy Mankind Pharma; target of Rs 2640: Motilal Oswal
Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 2640 in its research report dated April 29, 2026.
Buy Piramal Pharma; target of Rs 190: Motilal Oswal
Motilal Oswal is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 190 in its research report dated April 29, 2026.